Malaria Consortium Africa, Kampala
The Malaria Consortium Africa is internationally recognized for its work on communicable disease control and complementary health systems strengthening in Africa and Asia. The communicable diseases the Malaria Consortium works on include malaria, TB, diarrhoeal
diseases and neglected diseases. The focus of activities is on the implementation of new approaches, developing local capacity and scaling-up effective interventions. It offers high quality, technically sound and independent support to populations under threat from malaria and other communicable diseases. It works to deliver cost-effective interventions efficiently and on a large scale, with a special focus on poor and difficult to reach communities. MCA undertakes independent evaluations of global, regional and local health initiatives and promotes strengthening of regional and local organisations.
East & Southern Africa Regional Office
Plot 25, Upper Naguru East Road
P.O Box 8045, Kampala
Tel: +256 31 2 300 420
Fax: +256 31 2 300 425
FEAST trial Capacity building objectives for Uganda
- To conduct courses and bedside teaching to assist with the recognition and management of the sick or critically ill child. This is one of the major objectives of the site preparation and will consist of an on site taught course ETAT (Emergency Triage and Treatment) as well as bedside teaching courses by a consultant paeditrician. We aim to target personnel at every level of the care pathway in the child’s treatment.
- To provide a framework for implementation and evaluation of current guidelines for severely ill children- these can be updated with changes of national or international guidelines.
- To assist with clinical trials methodology training, including Good Clinical Practice and long distance taught courses.
- To indirectly provide reliable hospital data on the burden of severe disease in childhood including severe falciparum malaria- which may be important for future health planning and evaluation of malaria control measures.
- To integrate dedicated trial teams and assimilate trial participant care within the care of other patients on the ward.